Evidence map›Paper›PMID 41927524›Full record

ArticleBlood cancer journal2026

Molecular variants, clonal evolution and clinical relevance in pediatric and adult T-cell lymphoblastic neoplasia.

Sarah Sandmann, Marcel Te Vrugt, Gerrit Randau, Thomas Beder, Martin Neumann, Toni Lange, Amelie Alfert, Stephanie Mueller, Marc Hotfilder, Corinne Rossi and 7 more

Abstract read
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sarah Sandmann *Institute of Medical Data Science, Otto-von-Guericke-University, Magdeburg, Germany. sarah.sandmann@med.ovgu.de.ORCID 0000-0002-5011-0641
Marcel Te Vrugt *Pediatric Hematology and Oncology and NHL-BFM study center, University Hospital Muenster, Muenster, Germany.
Gerrit RandauPediatric Hematology and Oncology and NHL-BFM study center, University Hospital Muenster, Muenster, Germany.
Thomas BederA Clinical Research Unit "CATCH ALL" (KFO 5010/1) funded by the Deutsche Forschungsgemeinschaft, Kiel, Germany.ORCID 0009-0000-2278-5054
Martin NeumannDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
Toni LangeInstitute of Medical Data Science, Otto-von-Guericke-University, Magdeburg, Germany.ORCID 0009-0002-0939-8062
Amelie AlfertPediatric Hematology and Oncology and NHL-BFM study center, University Hospital Muenster, Muenster, Germany.
Stephanie MuellerPediatric Hematology and Oncology and NHL-BFM study center, University Hospital Muenster, Muenster, Germany.
Marc HotfilderPediatric Hematology and Oncology and NHL-BFM study center, University Hospital Muenster, Muenster, Germany.
Corinne RossiClinic for Pediatric Oncology, Hematology, Immunology, and Pneumology, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Cornelia EckertDepartment of Pediatric Oncology/Hematology, Charité Universitaetsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-1039-2872
Anja MoerickeDepartment of Pediatrics I, Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Kiel, Germany.
Johanna Maria HornsDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
Martin ZimmermannDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-0365-3512
Julian VargheseInstitute of Medical Data Science, Otto-von-Guericke-University, Magdeburg, Germany.
Monika BrüggemannDepartment of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
Birgit BurkhardtPediatric Hematology and Oncology and NHL-BFM study center, University Hospital Muenster, Muenster, Germany. birgit.burkhardt@ukmuenster.de.ORCID 0000-0002-1151-829X

Funding

Deutsche Kinderkrebsstiftung (German Childhood Cancer Foundation) DKS 2014.11Deutsche Kinderkrebsstiftung (German Childhood Cancer Foundation) DKS 2016.24Deutsche Krebshilfe (German Cancer Aid) 70112964 LBL 2018 trial
6 · The paper itself

Abstract

T-cell lymphoblastic lymphoma (T-LBL) and T-cell acute lymphoblastic leukemia (T-ALL) originate from thymic T-cell precursors, with ongoing debate on whether they are variants of the same disease or distinct entities. For 211 patients, including pediatric and adult T-ALL and T-LBL cases, targeted next-generation sequencing and SNP-arrays were performed, and single-nucleotide variants, indels and copy-number variants (CNVs) were analyzed. We aimed to assess genetic differences between T-ALL and T-LBL across age. Generally, mutational landscape analysis identified mutated PHF6 being associated with higher, NOTCH1 with lower age at diagnosis for both T-LBL and T-ALL. Association of CNVs with higher age was evident for T-ALL, but not T-LBL. Analysis of clonal evolution revealed that CNVs - especially deletions and LOH in chromosome 9 (LOH_in_9p) - were observed as first mutational event in both pediatric T-ALL and T-LBL. The sequence of genetic events, starting with LOH_in_9p followed by mutations in NOTCH1, was significantly more frequent in pediatric T-ALL and T-LBL. Detailed evaluation of the patients' individual clonal evolution indicated that the proportion of malignant cells without NOTCH

Indexed as

Clonal EvolutionPrecursor T-Cell Lymphoblastic Leukemia-LymphomaAdolescentAdultAgedChildChild, PreschoolDNA Copy Number VariationsFemaleHumansInfantMaleMiddle AgedMutationPolymorphism, Single NucleotideReceptor, Notch1Receptor, Notch1

Identifiers

PMID41927524
PMCPMC13066408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.